Payment overview · 2025
General Payments
$47.71
2 reported records · 2 companies
Healthcare provider profile · identity verified
Hanan Miller, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · BROOKLYN, NY · NPI 1437143377
Verified facts
What the public records show
CMS Open Payments records show Hanan Miller, M.D. received $47.71 in general payments during 2025 across 2 reported records.
ACADIA Pharmaceuticals Inc accounted for 50.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc | Unresolved — no canonical attribution shown | $23.95 | 50.2% | 1 | 2025 |
| SK Life Science, Inc. |
SK Life Science, Inc. exact · evidence 2025-04-03 |
$23.76 | 49.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $47.71 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| DAYBUE Normalized: daybue |
Drug | ACADIA Pharmaceuticals Inc | $23.95 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 493 | 76 |
| Gabapentin | Gabapentin | 412 | 71 |
| Famotidine | Famotidine | 350 | 49 |
| Eliquis | Apixaban | 330 | 50 |
| Furosemide | Furosemide | 326 | 57 |
| Losartan Potassium | Losartan Potassium | 278 | 44 |
| Tamsulosin Hcl | Tamsulosin Hcl | 273 | 35 |
| Atorvastatin Calcium | Atorvastatin Calcium | 238 | 74 |
| Clopidogrel | Clopidogrel Bisulfate | 220 | 32 |
| Levetiracetam | Levetiracetam | 217 | 25 |
| Pantoprazole Sodium | Pantoprazole Sodium | 206 | 50 |
| Latanoprost | Latanoprost | 189 | 31 |
| Nifedipine Er | Nifedipine | 181 | 29 |
| Memantine Hcl | Memantine Hcl | 180 | 24 |
| Metoprolol Succinate | Metoprolol Succinate | 174 | 42 |
| Metformin Hcl | Metformin Hcl | 165 | 28 |
| Levothyroxine Sodium | Levothyroxine Sodium | 146 | 25 |
| Hydralazine Hcl | Hydralazine Hcl | 145 | 23 |
| Mirtazapine | Mirtazapine | 145 | 26 |
| Metoprolol Tartrate | Metoprolol Tartrate | 140 | 33 |
| Lisinopril | Lisinopril | 115 | 15 |
| Donepezil Hcl | Donepezil Hcl | 113 | 21 |
| Finasteride | Finasteride | 110 | 16 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 106 | 12 |
| Buspirone Hcl | Buspirone Hcl | 105 | 16 |
| Divalproex Sodium | Divalproex Sodium | 99 | 15 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 99 | 15 |
| Carvedilol | Carvedilol | 98 | 24 |
| Xarelto | Rivaroxaban | 97 | 17 |
| Diclofenac Sodium | Diclofenac Sodium | 95 | 25 |
| Labetalol Hcl | Labetalol Hcl | 95 | 12 |
| Entresto | Sacubitril/Valsartan | 90 | 15 |
| Lactulose | Lactulose | 85 | 23 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 80 | 17 |
| Baclofen | Baclofen | 75 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 74 | 20 |
| Citalopram Hbr | Citalopram Hydrobromide | 73 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 68 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 68 | 15 |
| Allopurinol | Allopurinol | 64 | 14 |
| Calcitriol | Calcitriol | 63 | suppressed |
| Januvia | Sitagliptin Phosphate | 62 | 13 |
| Escitalopram Oxalate | Escitalopram Oxalate | 61 | 12 |
| Silver Sulfadiazine | Silver Sulfadiazine | 61 | 22 |
| Spironolactone | Spironolactone | 59 | 15 |
| Jardiance | Empagliflozin | 58 | 13 |
| Brimonidine Tartrate | Brimonidine Tartrate | 56 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 56 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 54 | 14 |
| Nystatin | Nystatin | 51 | 11 |
| Albuterol Sulfate | Albuterol Sulfate | 50 | 12 |
| Simvastatin | Simvastatin | 48 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 48 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 48 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 47 | 11 |
| Lokelma | Sodium Zirconium Cyclosilicate | 45 | suppressed |
| Insulin Lispro | Insulin Lispro | 44 | 13 |
| Doxazosin Mesylate | Doxazosin Mesylate | 42 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 41 | 16 |
| Insulin Aspart Flexpen | Insulin Aspart | 40 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 40 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 37 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 36 | suppressed |
| Hydrocortisone | Hydrocortisone | 35 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 34 | suppressed |
| Olanzapine | Olanzapine | 34 | suppressed |
| Potassium Chloride | Potassium Chloride | 34 | suppressed |
| Ssd | Silver Sulfadiazine | 34 | 15 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 33 | 12 |
| Enalapril Maleate | Enalapril Maleate | 33 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 33 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 32 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 32 | suppressed |
| Omeprazole | Omeprazole | 32 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 31 | suppressed |
| Clonazepam | Clonazepam | 31 | suppressed |
| Atenolol | Atenolol | 30 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 29 | 13 |
| Namzaric | Memantine Hcl/Donepezil Hcl | 29 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 29 | suppressed |
| Valsartan | Valsartan | 29 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 28 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 28 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 28 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 27 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 26 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 26 | suppressed |
| Rexulti | Brexpiprazole | 26 | suppressed |
| Rivastigmine | Rivastigmine | 26 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 25 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 25 | suppressed |
| Risperidone | Risperidone | 25 | suppressed |
| Tradjenta | Linagliptin | 25 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 25 | suppressed |
| Brilinta | Ticagrelor | 24 | suppressed |
| Dextrose 5%-0.45% Nacl | Dextrose 5 %-0.45 % Sod Chlord | 24 | 16 |
| Midodrine Hcl | Midodrine Hcl | 24 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 24 | suppressed |
| Meloxicam | Meloxicam | 22 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 22 | 13 |
| Amiodarone Hcl | Amiodarone Hcl | 21 | suppressed |
| Timolol Maleate | Timolol Maleate | 21 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 20 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 20 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 20 | suppressed |
| Methimazole | Methimazole | 20 | suppressed |
| Novolog Flexpen | Insulin Aspart | 20 | suppressed |
| Prednisone | Prednisone | 20 | suppressed |
| Torsemide | Torsemide | 20 | suppressed |
| Humalog | Insulin Lispro | 19 | suppressed |
| Ingrezza | Valbenazine Tosylate | 19 | suppressed |
| Tacrolimus | Tacrolimus | 19 | suppressed |
| Ketoconazole | Ketoconazole | 18 | suppressed |
| Pregabalin | Pregabalin | 18 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 17 | suppressed |
| Lamotrigine | Lamotrigine | 17 | suppressed |
| Levemir Flexpen | Insulin Detemir | 17 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 17 | suppressed |
| Novolog | Insulin Aspart | 17 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 17 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 16 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Halobetasol Propionate | Halobetasol Propionate | 16 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 16 | suppressed |
| Calcium Acetate | Calcium Acetate | 15 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 15 | suppressed |
| Ozempic | Semaglutide | 15 | suppressed |
| Aripiprazole | Aripiprazole | 14 | suppressed |
| Insulin Aspart | Insulin Aspart | 14 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 14 | suppressed |
| Cilostazol | Cilostazol | 13 | suppressed |
| Clonidine | Clonidine | 13 | suppressed |
| Haloperidol | Haloperidol | 13 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 13 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 13 | suppressed |
| Letrozole | Letrozole | 13 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 13 | suppressed |
| Lorazepam | Lorazepam | 13 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 13 | suppressed |
| Mupirocin | Mupirocin | 13 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 13 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 13 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 13 | suppressed |
| Selegiline Hcl | Selegiline Hcl | 13 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 13 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 12 | suppressed |
| Cephalexin | Cephalexin | 12 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 12 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 12 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 12 | suppressed |
| Securesafe Pen Needle | Pen Needle, Diabetic, Safety | 12 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 11 | suppressed |
| Cyclosporine | Cyclosporine | 11 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 11 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 11 | suppressed |
| Enulose | Lactulose | 11 | suppressed |
| Fenofibrate | Fenofibrate | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Restasis | Cyclosporine | 11 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 11 | suppressed |
| Trulicity | Dulaglutide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $47.71 · 2 records | ACADIA Pharmaceuticals Inc | DAYBUE | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error